Cargando…

Effect and safety of cytokine-induced killer (CIK) cell immunotherapy in patients with breast cancer: A meta-analysis

BACKGROUND: Breast cancer (BC) is considered a systemic disease with a primarily locoregional component. The accumulation of basic researches and clinical studies related to cytokine-induced killer (CIK) cells has confirmed their safety and feasibility in treating BC. By searching the PubMed, Embase...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Jianxin, Hu, Junfeng, Liu, Xiandong, Hu, Chao, Li, Ming, Han, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2017
Materias:	5750
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5662403/ https://www.ncbi.nlm.nih.gov/pubmed/29049237 http://dx.doi.org/10.1097/MD.0000000000008310

Ejemplares similares

Adjuvant ovarian suppression for premenopausal hormone receptor-positive breast cancer: A network meta-analysis
por: Jiang, Mengjie, et al.
Publicado: (2021)

Association between CASC16 rs4784227 polymorphism and breast cancer susceptibility: A meta-analysis
por: Liang, Xiong-Shun, et al.
Publicado: (2021)

Induced abortion and breast cancer: An updated meta-analysis
por: Deng, Yongchun, et al.
Publicado: (2018)

Association between serum cytokines and progression of breast cancer in Chinese population
por: Wang, Haiyan, et al.
Publicado: (2017)

Comparative efficacy and safety of metronomic chemotherapy in breast cancer: A protocol for network meta-analysis protocol
por: Xie, Ying, et al.
Publicado: (2021)

Hypoxia-mediated activation of hypoxia-inducible factor-1α in triple-negative breast cancer: A review
por: Liu, Lihui, et al.
Publicado: (2023)

Adoptive Immunotherapy Strategies with Cytokine-Induced Killer (CIK) Cells in the Treatment of Hematological Malignancies
por: Schmeel, Frederic Carsten, et al.
Publicado: (2014)

Refusal of cancer-directed surgery in male breast cancer
por: Wang, Shipei, et al.
Publicado: (2021)

A Case Report of Local Recurrence Developing 24 Years After Mastectomy for Breast Cancer Recurrence From Breast Cancer After 24 Years
por: Xiao, Linlin, et al.
Publicado: (2016)

Efficacy and safety of endocrine monotherapy as first-line treatment for hormone-sensitive advanced breast cancer: A network meta-analysis
por: Zhang, Jingwen, et al.
Publicado: (2017)

Efficacy and safety of Kanglaite injection combined with chemotherapy for women breast cancer: A protocol for systematic review and meta-analysis of randomized clinical trials
por: Cheng, Shengli, et al.
Publicado: (2021)

Immediate breast reconstruction using latissimus dorsi muscular flap: A retrospective study of Chinese patients with breast cancer
por: Liu, Qiuming, et al.
Publicado: (2021)

Expression profile of SIX family members correlates with clinic-pathological features and prognosis of breast cancer: A systematic review and meta-analysis
por: Xu, Han-Xiao, et al.
Publicado: (2016)

Multi-omics analysis revealing a senescence-relevant lncRNAs signature for the assessment of response to immunotherapy for breast cancer
por: Yu, Ziyi, et al.
Publicado: (2023)

A senescence-related signature for predicting the prognosis of breast cancer: A bioinformatics analysis
por: Xing, Tengfei, et al.
Publicado: (2023)

Imaging features of granular cell tumor in the breast: Case report
por: Zeng, Qiao, et al.
Publicado: (2020)

Impact of WNT1-inducible signaling pathway protein-1 (WISP-1) genetic polymorphisms and clinical aspects of breast cancer
por: Wang, Yan, et al.
Publicado: (2019)

Cytokine-induced killer (CIK) cell therapy for patients with hepatocellular carcinoma: efficacy and safety
por: Ma, Yue, et al.
Publicado: (2012)

The effects of case management for breast cancer patients: A protocol for systematic review and meta-analysis
por: Chai, Yong, et al.
Publicado: (2022)

Magnetic resonance imaging in screening women at high risk of breast cancer: A meta-analysis
por: Ding, Wu, et al.
Publicado: (2023)

Antrodia cinnamomea is a potentially effective complementary medicine for adjuvant therapy against breast cancer with bone metastasis: A case report
por: Long, Huei, et al.
Publicado: (2020)

Intracystic papillary carcinoma of the breast in males: Three case reports
por: Luo, Hua, et al.
Publicado: (2020)

Prognosis and clinicopathological characteristics of metaplastic breast cancer: A meta-analysis
por: Yang, Xiaolu, et al.
Publicado: (2022)

CalliSpheres drug-eluting beads transarterial-chemoembolization in the treatment of liver metastases from breast cancer: Initial experience in 14 patients
por: Chang, Xu, et al.
Publicado: (2021)

Potential value of MicroRNA-21 as a biomarker for predicting the prognosis of patients with breast cancer: A protocol for meta-analysis and bioinformatics analysis
por: Ding, Yunfeng, et al.
Publicado: (2021)

Vitamin D Receptor Polymorphism and Breast Cancer Risk: A Meta-Analysis
por: Lu, Demin, et al.
Publicado: (2016)

Methodological quality evaluation of systematic reviews or meta-analysis of trastuzumab-based therapy for breast cancer: A systematic review
por: Wei, Hua, et al.
Publicado: (2021)

Apatinib + CPT-11 + S-1 for treatment of refractory brain metastases in patient with triple-negative breast cancer: Case report and literature review
por: Hu, Ting, et al.
Publicado: (2018)

Cytokine-induced killer (CIK) cells: from basic research to clinical translation
por: Guo, Yelei, et al.
Publicado: (2015)

Diabetes mellitus and prognosis in women with breast cancer: A systematic review and meta-analysis
por: Zhao, Xiao-Bo, et al.
Publicado: (2016)

The efficacy of gefitinib supplementation for breast cancer: A meta-analysis of randomized controlled studies
por: Ye, Jing, et al.
Publicado: (2020)

Effect of aspirin use on survival benefits of breast cancer patients: A meta-analysis
por: Liu, Jiamin, et al.
Publicado: (2021)

Influence of occupation and education level on breast cancer stage at diagnosis, and treatment options in China: A nationwide, multicenter 10-year epidemiological study
por: Liu, Yang, et al.
Publicado: (2017)

Effect of BRCA germline mutations on breast cancer prognosis: A systematic review and meta-analysis
por: Baretta, Zora, et al.
Publicado: (2016)

Prognostic role of pretreatment neutrophil to lymphocyte ratio in breast cancer patients: A meta-analysis
por: Liu, Xu, et al.
Publicado: (2017)

Prognostic and clinicopathological significance of cyclin B expression in patients with breast cancer: A meta-analysis
por: Sun, Xi, et al.
Publicado: (2017)

MicroRNAs in the prognosis of triple-negative breast cancer: A systematic review and meta-analysis
por: Lü, Lingshuang, et al.
Publicado: (2017)

Prognosis of COVID-19 in patients with breast cancer: A protocol for systematic review and meta-analysis
por: Sheng, Zhijuan, et al.
Publicado: (2020)

The relationship between exposure to particulate matter and breast cancer incidence and mortality: A meta-analysis
por: Zhang, Zhe, et al.
Publicado: (2019)

LEP as a potential biomarker in prognosis of breast cancer: Systemic review and meta analyses (PRISMA)
por: Jin, Tong Yi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_sv5nebv54isfpauenback22a4i